IOL Chemicals & Pharmaceuticals Quarterly Results for Trading Insights
IOLCP • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹30 Cr
QSept 2025
IOL Chemicals & Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹574 Cr in Sept 2025 (+7.9% vs Mar 2025, +7.9% vs Sept 2024)
- Net Profit of ₹30 Cr in Sept 2025 (-3.2% vs Mar 2025, +57.9% vs Sept 2024)
- EBITDA of ₹64 Cr in Sept 2025 (-4.5% vs Mar 2025)
- Operating Margin of 10.0% in Sept 2025 (-2.0pp vs Mar 2025)
- Earnings Per Share of ₹1.02 in Sept 2025 (-4.7% vs Mar 2025)
IOL Chemicals & Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 574 | 532 | 559 | 532 | 511 | 7.9% | 7.9% |
| Net Profit (₹ Cr) | 30 | 31 | 34 | 19 | 28 | - | - |
| EBITDA (₹ Cr) | 64 | 67 | 70 | 48 | 57 | - | - |
| EPS (₹) | 1.02 | 1.07 | 1.16 | 3.26 | 4.71 | - | - |
| Operating Margin (%) | 10.0% | 12.0% | 11.0% | 8.0% | 10.0% | - | - |
IOL Chemicals & Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize IOL Chemicals & Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in IOL Chemicals & Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for IOL Chemicals & Pharmaceuticals
Additional stock information and data for IOLCP
Revenue Trend (₹ Cr)
Sept 2024
532
Jun 2025
559
Mar 2025
532
Sept 2025
574
Net Profit Trend (₹ Cr)
Sept 2024
19
Jun 2025
34
Mar 2025
31
Sept 2025
30
Operating Margin Trend (%)
Sept 2024
8.0%
Jun 2025
11.0%
Mar 2025
12.0%
Sept 2025
10.0%
Sector Competitors - Quarterly Performance Comparison
Comparing IOL Chemicals & Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹412,613.60 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹169,700.80 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹129,171.09 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,570.84 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores